BG Medicine, Inc. Announces 510(k) Filing for the ARCHITECT Galectin-3 Assay ... MarketWatch (press release) BG Medicine currently markets a manual version of its galectin-3 blood test, the BGM Galectin-3(R) test, which was cleared by the FDA as an aid in assessing the prognosis of patients diagnosed with chronic heart failure. To date, data have shown that ... |
